Currently, there are three FDA-approved forms of semaglutide: Ozempic is a subcutaneous injection for type 2 diabetes
For example, using Ozempic, which is FDA-approved for diabetes, for weight loss
Some people sail through with minimal discomfort, while others find the nausea challenging enough to interfere with daily activities
Only 4.2% of participants discontinued due to side effects after week 24, indicating that side effects become manageable or resolve entirely for the vast majority who continue treatment
Participants received weekly injections of the highest tolerated doses of Zepbound, either 10 milligrams or 15 milligrams, or Wegovy, 1.7 milligrams or 2.4 milligrams
The relative risk was 0.76, actually trending slightly lower than placebo, though not statistically significant